EMJ Urology 12 [Supplement 1] . 2024

In this issue

Androgen deprivation therapy (ADT) continues to be central to the treatment of advanced prostate cancer (PCa). This article summarises data presented at the Global Congress on Prostate Cancer (PROSCA) 2023, held in Málaga, Spain, focusing on practical approaches to the use of ADT in complex clinical scenarios.